Commodore International Ltd. operates as an investment holding company. The company is headquartered in West Chester, Pennsylvania and currently employs 3,067 full-time employees. The company went IPO on 2001-12-28.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
4
3
4
4
2
4
Research & Development
4
5
4
5
4
6
Operating Expenses
8
9
8
9
7
11
Other Non Operating Income (Expenses)
0
0
0
--
--
--
Pretax Income
-6
-5
-7
-8
-6
-23
Income Tax Expense
0
0
0
0
0
-1
Net Income
-6
-5
-7
-7
-5
-22
Net Income Growth
0%
-28.99%
0%
40%
-77%
120%
Shares Outstanding (Diluted)
2,526.72
495.27
31.58
0.49
0
0
Shares Change (YoY)
19,154%
1,468%
6,291%
247,000%
100%
0%
EPS (Diluted)
0
-0.01
-0.22
-15.49
-27,300
-201,718.18
EPS Growth
-99%
-95%
-99%
-100%
-86%
0%
Free Cash Flow
-11
-13
-7
-7
-6
-9
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
-8
-9
-8
-8
-6
-9
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
1
EBIT
-8
-9
-8
-8
-6
-10
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
4.34%
Follow-Up Questions
What are Commodore International Ltd's key financial statements?
According to the latest financial statement (Form-10K), Biodexa Pharmaceuticals PLC has a total asset of $14, Net loss of $-5
What are the key financial ratios for CBUIF?
Biodexa Pharmaceuticals PLC's Current ratio is 2.33, has a Net margin is 0, sales per share of $0.
How is Commodore International Ltd's revenue broken down by segment or geography?
Biodexa Pharmaceuticals PLC largest revenue segment is Pipeline Research and Development, at a revenue of 473,602 in the most earnings release.For geography, Belgium is the primary market for Biodexa Pharmaceuticals PLC, at a revenue of 473,602.
Is Commodore International Ltd profitable?
no, according to the latest financial statements, Biodexa Pharmaceuticals PLC has a net loss of $-5
Does Commodore International Ltd have any liabilities?
yes, Biodexa Pharmaceuticals PLC has liability of 6
How many outstanding shares for Commodore International Ltd?
Biodexa Pharmaceuticals PLC has a total outstanding shares of 668.59